intimation of Appointment of Secretarial Auditor of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories has informed the stock exchange that its Board, on the recommendation of the Audit Committee, has approved the appointment of M/s. Arvind Sudra & Associates, Company Secretaries, as the new Secretarial Auditor of the company. The appointment is for a term of five consecutive years, covering the period from the conclusion of the upcoming 83rd Annual General Meeting (AGM) until the conclusion of the 88th AGM, and is subject to shareholder approval at the ensuing AGM. The firm, led by CS Arvind Sudra (a member of ICSI with about 20 years of experience), will handle secretarial audit responsibilities under Section 204 of the Companies Act, 2013. Note: The BSE filing label mentions Star Source Multi Trade Ltd, but the actual document is from Chemo Pharma Laboratories Ltd.
This is a routine governance-related appointment and does not materially affect the company's financials or operations. Shareholders will get to vote on this appointment at the upcoming AGM, but it carries no direct impact on stock price or business performance.